Patrick Lu

Patrick Lu

Company: Siranomics

Job title: President & CEO


Clinical Study Readouts for Novel RNAi Cancer Therapeutics 9:00 am

Advantage of polypeptide nanoparticle delivery for siRNA cancer therapeutics STP705 local formulation for treatment of non-melanoma skin cancers STP707 systemic formulation for treatment of liver and pancreatic cancersRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.